Labcorp Long-Term Investments 2010-2024 | LH

Labcorp long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  • Labcorp long-term investments for the quarter ending September 30, 2024 were $0.017B, a 57.22% decline year-over-year.
  • Labcorp long-term investments for 2023 were $0.027B, a 59.06% decline from 2022.
  • Labcorp long-term investments for 2022 were $0.066B, a 7.88% increase from 2021.
  • Labcorp long-term investments for 2021 were $0.061B, a 17.14% decline from 2020.
Labcorp Annual Long-Term Investments
(Millions of US $)
2023 $27
2022 $66
2021 $61
2020 $74
2019 $85
2018 $61
2017 $58
2016 $58
2015 $58
2014 $93
2013 $89
2012 $78
2011 $77
2010 $79
2009 $71
Labcorp Quarterly Long-Term Investments
(Millions of US $)
2024-09-30 $17
2024-06-30 $18
2024-03-31 $18
2023-12-31 $27
2023-09-30 $40
2023-06-30 $67
2023-03-31 $66
2022-12-31 $66
2022-09-30 $64
2022-06-30 $58
2022-03-31 $62
2021-12-31 $61
2021-09-30 $62
2021-06-30 $82
2021-03-31 $85
2020-12-31 $74
2020-09-30 $71
2020-06-30 $72
2020-03-31 $67
2019-12-31 $85
2019-09-30 $86
2019-06-30 $87
2019-03-31 $67
2018-12-31 $61
2018-09-30 $58
2018-06-30 $59
2018-03-31 $58
2017-12-31 $58
2017-09-30 $65
2017-06-30 $67
2017-03-31 $58
2016-12-31 $58
2016-09-30 $60
2016-06-30 $62
2016-03-31 $61
2015-12-31 $58
2015-09-30 $62
2015-06-30 $69
2015-03-31 $89
2014-12-31 $93
2014-09-30 $95
2014-06-30 $97
2014-03-31 $87
2013-12-31 $89
2013-09-30 $87
2013-06-30 $88
2013-03-31 $87
2012-12-31 $78
2012-09-30 $81
2012-06-30 $79
2012-03-31 $80
2011-12-31 $77
2011-09-30 $75
2011-06-30 $79
2011-03-31 $83
2010-12-31 $79
2010-09-30 $80
2010-06-30 $71
2010-03-31 $69
2009-12-31 $71
2009-09-30 $75
2009-06-30 $69
2009-03-31 $64
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.088B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
West Pharmaceutical Services (WST) United States $23.239B 47.47
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
CONMED (CNMD) United States $2.215B 18.48
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49